CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	6 Months Ended
Jun. 30, 2021	Jun. 30, 2020
Cash flows from operating activities:
Net income	$ 36,752	$ 18,243
Adjustments to reconcile net income to net cash provided by operating activities:
(Credit) provision for credit losses	(4,264)	22,340
Depreciation and amortization of premises and equipment	3,293	3,010
Non-cash lease (benefit) expense	(34)	117
Cash flows from operating leases	(3,325)	(3,189)
Loss on disposal of fixed assets	37	0
Loss on sale of other real estate, net of write-downs	0	70
Amortization of mortgage servicing rights	2,082	3,217
Net amortization and accretion of premium/discounts on investment securities	5,715	4,327
Share-based compensation expense	1,340	1,396
Investment securities gains (losses)	(50)	0
Net gain on sales of residential mortgage loans	(3,654)	(5,273)
Proceeds from sales of loans held for sale	89,016	167,643
Originations of loans held for sale	(74,036)	(163,730)
Equity in earnings of unconsolidated subsidiaries	(187)	(130)
Distributions from unconsolidated subsidiaries	288	121
Net increase in cash surrender value of bank-owned life insurance	(2,685)	(2,268)
Deferred income taxes	(8,612)	(2,129)
Net tax benefit (expense) from share-based compensation	252	(134)
Net change in other assets and liabilities	17,212	13,427
Net cash provided by operating activities	59,140	57,058
Cash flows from investing activities:
Proceeds from maturities of and calls on investment securities available-for-sale	169,385	123,720
Proceeds from sales of investment securities available-for-sale	174,971	0
Purchases of investment securities available-for-sale	(596,140)	(147,359)
Net loan repayments (originations)	3,765	(524,869)
Purchases of loan portfolios	(118,194)	(33,196)
Proceeds from sale of foreclosed loans/other real estate owned	0	94
Purchases of bank-owned life insurance	(3,550)	0
Proceeds from bank-owned life insurance	2,107	166
Net purchases of premises, equipment and land	(14,792)	(11,699)
Contributions to unconsolidated subsidiaries	(2,819)	(2,194)
Net proceeds from redemption of FHLB stock	88	5,754
Net cash used in investing activities	(385,179)	(589,583)
Cash flows from financing activities:
Net increase in deposits	601,041	674,662
Proceeds from long-term debt	0	65,944
Net decrease in short-term borrowings	(22,000)	(150,000)
Cash dividends paid on common stock	(13,277)	(12,971)
Repurchases of common stock and other related costs	(4,327)	(4,749)
Net proceeds from issuance of common stock and stock option exercises	1,013	0
Net cash provided by financing activities	562,450	572,886
Net increase in cash and cash equivalents	236,411	40,361
Cash and cash equivalents at beginning of period	104,067	102,972
Cash and cash equivalents at end of period	340,478	143,333
Cash paid during the period for:
Interest	4,460	11,069
Income taxes	14,358	185
Supplemental disclosure of non-cash information:
Net change in common stock held by directors’ deferred compensation plan	$ 191	$ 154

The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets, and the amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of a finite-lived intangible asset to fair value.

No definition available.